摘要
目的:观察布地奈德混悬液雾化吸入治疗小儿轻中度急性喉炎的临床疗效。方法将我院小儿内科2012年2月~2014年12月入选的轻、中度急性喉炎的患者91例为研究对象,随机分为治疗组(46例)和对照组(45例),治疗组采用布地奈德混悬液(普米克令舒)雾化吸入,对照组采用了地塞米松静滴,两组均治疗3 d后再进行疗效评定。结果治疗组总有效率(89.6%)高于对照组(53.3%),两者比较有差异,具有统计学意义(P<0.05)。结论布地奈德混悬液采用雾化吸入的方式直接迅速作用于靶器官,疗效高,不良反应发生率低。
Objective To observe the clinical curative effect of budesonide suspension liquid atomization inhalation for the treatment of children with mild-to-moderate acute laryngitis. Methods To pediatric medicine in February 2012 to December 2014 selected 91 patients with mild and moderate acute laryngitis as the research object,were randomly divided into treatment group(46 cases)and control group(45 cases),the treatment group with budesonide suspension liquid atomization inhalation,control group used the dexamethasone static drops,the two groups after treatment for 3 days and then we assessed the efficacy. ResultsTreatment group total effective rate(89.6%)was significantly higher than the control group(53.3%),the more obvious differences,statisticaly significant(P〈 0.05). ConclusionBudesonide suspension liquid by means of atomization inhalation directly ACTS on the target organs rapidly,high curative effect,low incidence of adverse reactions.
出处
《中国卫生标准管理》
2015年第20期111-112,共2页
China Health Standard Management
关键词
急性喉炎
布地奈德混悬液
雾化吸入
Acute laryngitis
Budesonide mixed suspension
Atomization inhalation